Answer
Feb 03, 2026 - 08:03 AM
This medication is a selective TRK inhibitor, meaning it blocks the activity of tropomyosin receptor kinases (TRKs) involved in the growth and spread of cancer cells with NTRK gene fusions. By inhibiting TRK, the drug stops cancer cells from growing and spreading. TRK inhibitors are valuable because they offer precision treatment based on the genetic profile of the tumor.
